Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing combination chemotherapy to no treatment after surgical resection in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2013-03-26Clinical Trial Update: A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 window-of-opportunity trial of Afatinib in early-stage non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial comparing 99mTc-EC-DG SPECT/CT with 18F FDG PET/CT in patients with Non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 pharmacokinetic and radiation dosimetry study evaluating the Technetium-99m EC-DG radiopharmaceutical with SPECT/CT in patients wi…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab
This clinical trial update describes the completion of an observational post-authorization study evaluating the combination of carboplatin, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2013-03-14Clinical Trial Update: Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing panitumumab plus pemetrexed and cisplatin (PemCisP) with pemetrexed and cisplatin (PemCis) as first-line treatment f…
-
FDA approval · 2013-03-13FDA Approved: ALIMTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ALIMTA (pemetrexed disodium) from Eli Lilly and Company, updating its labeling with addition…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery [Phase 3]
SWOG's Phase 3 trial S0002 evaluating quitting smoking with or without bupropion in patients with Stage I or II non-small cell lung cancer a…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer [Phase 2]
This updates a Phase II neoadjuvant trial of dasatinib in early-stage non-small cell lung cancer; the study was terminated and results were …
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer [Phase 1]
A phase 1 trial evaluating cediranib maleate in combination with whole-brain radiation therapy for brain metastases in non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC) [NA]
This clinical trial update describes investigating stereotactic body radiotherapy for early-stage non-small cell lung cancer. The trial stat…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer [Phase 3]
This document reports the completion of a Phase 3 clinical trial comparing oral topotecan to intravenous docetaxel in pretreated, advanced n…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [NA]
Clinical trial update on combining radiofrequency ablation with external-beam radiation therapy for Stage I non-small cell lung cancer not a…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients [Phase 2, Phase 3]
Clinical trial update on a Phase 2/Phase 3 study evaluating Qingshu-Yiqi-Tang, an astragalus-based formula, for modulating immune alteration…
-
FDA approval · 2013-02-28FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Erlotinib for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of gemcitabine, carboplatin, and bortezomib in advanced or recurrent non-small cell lung cancer has completed. Sponsored by th…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating gefitinib for stage IIIB or stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
This is a Phase 2 randomized trial comparing erlotinib plus ARQ 197 versus erlotinib plus placebo in previously treated locally advanced or …
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated adding bevacizumab to standard chemotherapy for advanced, metastatic, or recurrent non-small cell lung cancer; t…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer [Phase 2]
Phase II trial evaluating Triapine in combination with Gemcitabine as second-line treatment for recurrent non-small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating whether adding Gefitinib to combination chemotherapy and radiation therapy improves outcomes for unresectable sta…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating ixabepilone and carboplatin with or without bevacizumab in advanced non-small-cell lung cancer has completed, wit…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial results for gefitinib retreatment in non-small cell lung cancer have been posted following completion of the study.